HWM
RMD icon

HB Wealth Management’s ResMed RMD Stock Holding History

HB Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$860K Sell
4,413
-225
-5% -$46.6K ﹤0.01% 808
2026
Q1 		$1.04M Buy
4,638
+646
+16% +$161K 0.01% 646
2025
Q4 		$962K Buy
3,992
+238
+6% +$60.9K 0.01% 640
2025
Q3 		$1.03M Buy
3,754
+382
+11% +$104K 0.01% 594
2025
Q2 		$870K Sell
3,372
-3
-0.1% -$716 0.01% 574
2025
Q1 		$755K Buy
3,375
+301
+10% +$70.3K 0.01% 626
2024
Q4 		$703K Buy
3,074
+26
+0.9% +$6.26K 0.01% 513
2024
Q3 		$744K Buy
3,048
+317
+12% +$70.8K 0.01% 458
2024
Q2 		$523K Buy
2,731
+481
+21% +$97.6K 0.01% 533
2024
Q1 		$446K Buy
2,250
+92
+4% +$16.9K 0.01% 542
2023
Q4 		$371K Buy
2,158
+652
+43% +$100K 0.01% 534
2023
Q3 		$223K Buy
+1,506
New +$272K ﹤0.01% 671

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HB Wealth Management's RMD Position: Q2 2026 in Review

HB Wealth Management reduced its ResMed (RMD) stake by 4.9% in Q2 2026, selling an estimated $46.6K and leaving 4,413 shares worth $860K. The position accounts for ﹤0.01% of the portfolio, ranked #808.

HB Wealth Management first reported a position in RMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.04M in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • HB Wealth Management held 4,413 shares of ResMed worth $860K as of Q2 2026.
  • HB Wealth Management sold 225 ResMed shares in Q2 2026, an estimated $46.6K.
  • ResMed made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #808 holding.
  • HB Wealth Management first reported a position in ResMed in Q3 2023 and has held it in 12 quarters since.
  • HB Wealth Management's ResMed position peaked at $1.04M in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.